| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/12/2006 | EP1430055B1 7-tert-butyl-3-(2-fluorophenyl)-6-(2h-¬1,2,4|triazol-3-ylmethoxy)-¬1,2,4|triazolo¬4,3-b|pyridazine for the treatment of anxiety and convulsions |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1427730B1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| 07/12/2006 | EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 07/12/2006 | EP1389212B1 3,7-diazabicyclo 3.3.1| formulations as anti-arrythmic compounds |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1325748B1 Cyanidin mixture for the treatment of large intestine cancer |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | EP1289557B1 Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor |
| 07/12/2006 | EP1263435B1 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 07/12/2006 | EP1254253B1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 07/12/2006 | EP1237559B1 Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran |
| 07/12/2006 | EP1222163B1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 07/12/2006 | EP1124950B1 Morpholino based p53 antisense oligonucleotide, and uses thereof |
| 07/12/2006 | EP1071764B1 Antisense oligonucleotides for the inhibition of integrin alphav-subunit expression |
| 07/12/2006 | EP1052977A4 Treatment of chronic inflammatory disorders of the gastrointestinal tract |
| 07/12/2006 | EP1037929B1 Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby |
| 07/12/2006 | EP1025846B1 Aqueous liquid preparations |
| 07/12/2006 | EP1023074B1 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 07/12/2006 | EP1020429B1 Sphingosine derivatives and medicinal composition |
| 07/12/2006 | EP0971743B1 Stabilized medicaments containing cysteinyl derivatives |
| 07/12/2006 | EP0970114B1 Neoglycoproteins |
| 07/12/2006 | EP0900235B1 Fragments of cr1 and their use |
| 07/12/2006 | EP0863744B1 Lipoic acid in topical compositions |
| 07/12/2006 | EP0788359B1 Combination of dextromethorphan with quinidine or quinine sulfate for treating a variety of intractable disorders |
| 07/12/2006 | CN1802545A Process for increasing liquid extraction from fabrics |
| 07/12/2006 | CN1802383A Colchicoside analogues |
| 07/12/2006 | CN1802380A Use of vinca alkaloid and its salt |
| 07/12/2006 | CN1802378A Beta-strand mimetics and method relating thereto |
| 07/12/2006 | CN1802377A Tricyclic compound |
| 07/12/2006 | CN1802376A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 07/12/2006 | CN1802375A Beta-carbolines useful for treating inflammatory disease |
| 07/12/2006 | CN1802372A 7-[(1,3-thiazol-2-yl)thio]-coumarin derivatives and their use as leukotriene biosynthesis inhibitors |
| 07/12/2006 | CN1802370A Aroyl semicarbazide derivatives against thromboembolic diseases |
| 07/12/2006 | CN1802369A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 07/12/2006 | CN1802368A Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 07/12/2006 | CN1802367A Imidazole derivatives as glutmate receptor antagonists |
| 07/12/2006 | CN1802366A C-glycoside derivatives and salts thereof |
| 07/12/2006 | CN1802361A M-stage kinesin inhibitor |
| 07/12/2006 | CN1802360A 1,2,4-oxadiazole benzoic acid compounds |
| 07/12/2006 | CN1802357A Aminopyrimidine derivatives and their medical use |
| 07/12/2006 | CN1802356A Alkylated iminodibenzyls as antioxidants |
| 07/12/2006 | CN1802355A Aminoalcohol derivatives |
| 07/12/2006 | CN1802354A Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/12/2006 | CN1802353A Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 07/12/2006 | CN1802352A Process for producing levetiracetam |
| 07/12/2006 | CN1802351A Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 07/12/2006 | CN1802350A Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders |
| 07/12/2006 | CN1802349A Treatment of lung cancer with active vitamin D compounds in combination with other treatments |
| 07/12/2006 | CN1802348A Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 07/12/2006 | CN1802345A Highly pure bases of 3,3-diphenyl propylamine monoesters |
| 07/12/2006 | CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 07/12/2006 | CN1802179A Compositions containing piperacillin and tazobactam useful for injection |
| 07/12/2006 | CN1802178A Solid formulation |
| 07/12/2006 | CN1802177A Inhibitors of phosphodiesterases in infertility |
| 07/12/2006 | CN1802172A Therapeutic composition for autoimmune conditions |
| 07/12/2006 | CN1802168A Sigma ligands for neuronal regeneration and functional recovery |
| 07/12/2006 | CN1802165A Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil |
| 07/12/2006 | CN1802162A Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| 07/12/2006 | CN1802161A Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
| 07/12/2006 | CN1802160A Use of heterocyclic compounds as SCCE inhibitors |
| 07/12/2006 | CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 07/12/2006 | CN1802158A Pharmaceutical compositions for nasal delivery |
| 07/12/2006 | CN1802157A Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| 07/12/2006 | CN1802156A Aminoquinoline compounds |
| 07/12/2006 | CN1802155A Neurocyte protective agent |
| 07/12/2006 | CN1802154A Pyridine N-oxides as antiviral agents |
| 07/12/2006 | CN1802153A Treatment of cognitive impairment using a selective dopamine D1 receptor agonist |
| 07/12/2006 | CN1802152A Improved treatment of cancer with glutamine |
| 07/12/2006 | CN1802151A Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
| 07/12/2006 | CN1802149A Pharmaceutical composition comprising N((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation |
| 07/12/2006 | CN1802102A Enteral composition for the prevention and/or treatment of sepsis |
| 07/12/2006 | CN1802101A Use of isomalt (mixture of 1,6 GPS and 1,1 GPM) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things |
| 07/12/2006 | CN1802091A Use of isoindolinone derivatives as insecticides |
| 07/12/2006 | CN1800238A Aliphatic polyester-polyamino acids copolymer with biological function and its synthesis method |
| 07/12/2006 | CN1800221A Hydroxypropyl- sulfobutyl-beta- cyclodextrin and its preparation method, analytical method and pharmaceutical uses |
| 07/12/2006 | CN1800219A 'Wood Frog Polysaccharide' capsule |
| 07/12/2006 | CN1800198A Method for preparing macrolides half-synthesized antibiotics telithromycin |
| 07/12/2006 | CN1800187A Taspine alkaline preparation method and uses in preparing medicine for treating tumour |
| 07/12/2006 | CN1800186A Adenosine a2a receptor antagonists |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1800184A Synthesis of temozolomide and analogs |
| 07/12/2006 | CN1800182A N2-arylformyl-4-ammonia/amidopteridine analog compound capable of regulating nitrous oxide synthase acitivity |
| 07/12/2006 | CN1800177A Reduced aminate of geniposide huperzine A and its preparation method and uses |
| 07/12/2006 | CN1800176A Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 07/12/2006 | CN1800175A Amino alcohol derivatives |
| 07/12/2006 | CN1800167A Anaerobe resistant compound |
| 07/12/2006 | CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 07/12/2006 | CN1799639A Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method |
| 07/12/2006 | CN1799631A Animal model for fetal alcohol syndrome and methods of treatment |
| 07/12/2006 | CN1799630A Chitosan-immune RNA composite formulation and preparation method thereof |
| 07/12/2006 | CN1799596A Pharmaceutical composition for treating cerebral apoplexy and its preparation method |
| 07/12/2006 | CN1799581A Moutan bark effective constituent and preparation method thereof |
| 07/12/2006 | CN1799574A Anti-depression formulations |
| 07/12/2006 | CN1799568A Preparation method of medicine for coronary heart disease treating angina pectoris and chest oppression feeling |
| 07/12/2006 | CN1799559A Chinese medicinal gel formulation, its preparation process and quality control method |
| 07/12/2006 | CN1799556A Anti-drowsiness aromatic agent |
| 07/12/2006 | CN1799554A Mannosan peptide injection and preparation method thereof |
| 07/12/2006 | CN1799553A Thrombus dissolving tablet and preparation |
| 07/12/2006 | CN1799552A Single sialic acid tetrahexose ganglioside preparation method |